Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 399-403

  Uchida, Haruhito A ^a   Kristo, Fjoralba ^a   Rateri, Debra L ^a   Lu, Hong ^a   Charnigo, Richard ^b   Cassis, Lisa A ^b   Daugherty, Alan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aneurysm; Angiotensin II; Atherosclerosis; Lymphocytes

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CHOLESTEROL; RAG1 PROTEIN;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY DILATATION; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS BREEDING; FEMALE; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE;

ANEURYSM; ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HYPERCHOLESTEROLEMIA; LYMPHOCYTES; MALE; MICE; T-LYMPHOCYTES;

EID: 77955240754     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.034     Document Type: Article

References (34)

1. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105:1605-1612.
2. Weiss D., Kools J.J., Taylor W.R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation 2001, 103:448-454.
3. Roselaar S.E., Kakkanathu P.X., Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996, 16:1013-1018.
4. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995, 92:8264-8268.
5. Rajavashisth T., Qiao J.H., Tripathi S., Tripathi J., Mishra N., Hua M., Wang X.P., Loussararian A., Clinton S., Libby P., Lusis A. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 1998, 101:2702-2710.
6. Babamusta F., Rateri D.L., Moorleghen J.J., Howatt D.A., Li X.A., Daugherty A. Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice. Atherosclerosis 2005, 186:282-290.
7. Dansky H.M., Charlton S.A., Harper M.M., Smith J.D.T. B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997, 94:4642-4646.
8. Daugherty A., Pure E., Delfel-Butteiger D., Chen S., Leferovich J., Roselaar S.E., Rader D.J. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E -/- mice. J Clin Invest 1997, 100:1575-1580.
9. Wang Y.X., Martin McNulty B., Freay A.D., Sukovich D.A., Halks Miller M., Li W.W., Vergona R., Sullivan M.E., Morser J., Dole W.P., Deng G.G. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 2001, 159:1455-1464.
10. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1621-1626.
11. Ocana E., Bohorquez J.C., Perez-Requena J., Brieva J.A., Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 2003, 170:39-48.
12. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
13. Cassis L.A., Rateri D.L., Lu H., Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007, 27:380-386.
14. Daugherty A., Whitman S.C. Quantification of atherosclerosis in mice. Methods Mol Biol 2003, 209:293-309.
15. Lu H., Rateri D.L., Cassis L.A., Daugherty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep 2008, 10:99-106.
16. Henriques T.A., Huang J., D'Souza S.S., Daugherty A., Cassis L.A. Orchiectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E deficient mice. Endocrinology 2004, 145:3866-3872.
17. Henriques T., Zhang X., Yiannikouris F.B., Daugherty A., Cassis L.A. Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:1251-1256.
18. Bruemmer D., Collins A.R., Noh G., Wang W., Territo M., Arias-Magallona S., Fishbein M.C., Kintscher U., Fleck E., Law R.E., Hsueh W.A., Angiotensin II accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin deficient mice. J Clin Invest 2003, 112:1318-1331.
19. Thomas M., Gavrila D., McCormick M.L., Miller F.J., Daugherty A., Cassis L.A., Dellsperger K.C., Weintraub N.L. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 2006, 114:404-413.
20. Lu H., Cassis L.A., Daugherty A. Atherosclerosis and arterial blood pressure in mice. Curr Drug Targets 2007, 8:1181-1189.
21. Cassis L.A., Gupte M., Thayer S., Zhang X., Charnigo R., Howatt D.A., Rateri D.L., Daugherty A. Angiotensin II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 2009, 296:H1660-1665.
22. Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D.G. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204:2449-2460.
23. Nickenig G., Jung O., Strehlow K., Zolk O., Linz W., Scholkens B.A., Bohm M. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 1997, 272:H2701-H2707.
24. Bonthu S., Heistad D.D., Chappell D.A., Lamping K.G., Faraci F.M. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 1997, 17:2333-2340.
25. Elhage R., Clamens S., Reardon Alulis C., Getz G.S., Fievet C., Maret A., Arnal J.F., Bayard F. Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology 2000, 141:462-465.
26. Reardon C.A., Blachowicz L., White T., Cabana V., Wang Y.G., Lukens J., Bluestone J., Getz G.S. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21:1011-1016.
27. Song L., Leung C., Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest 2001, 108:251-259.
28. Wassmann S., Czech T., Van Eickels M., Fleming I., Bohm M., Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/Angiotensin II type 1A receptor double-knockout mice. Circulation 2004, 110:3062-3067.
29. Daugherty A., Rateri D.L., Lu H., Inagami T., Cassis L.A. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004, 110:3849-3857.
30. Lu H., Rateri D.L., Feldman D.L., Charnigo R.J., Fukamizu A., Ishida J., Oesterling E.G., Cassis L.A., Daugherty A. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 2008, 118:984-993.
31. King V.L., Lin A.Y., Kristo F., Anderson T.J., Ahluwalia N., Hardy G.J., Owens A.P., Howatt D.A., Shen D., Tager A.M., Luster A.D., Daugherty A., Gerszten R.E. Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 2009, 119:426-435.
32. Sendobry S.M., Cornicelli J.A., Welch K., Grusby M.J., Daugherty A. Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo. J Immunol 1998, 161:1477-1482.
33. Grundy M.A., Sentman C.L. Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues. Exp Cell Res 2006, 312:3920-3926.
34. Manning M.W., Cassis L.A., Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003, 23:483-488.